Novel bioconversion products of andrographolide by Aspergillus ochraceus and their cytotoxic activities against human tumor cell lines

被引：9
|
作者：
He, Xiangjiu [1 ]
Wang, Yihai [1 ]
Hu, Hui [1 ]
Wu, Yixuan [1 ]
Zeng, Xiaobin [1 ]
机构：
[1] Wuhan Univ, Coll Pharm, Wuhan 430071, Peoples R China
来源：
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC | 2011年 / 68卷 / 01期
关键词：
Andrographolide; Aspergillus ochraceus; Hydroxylation; Microbial conversion; Cytotoxicity; CYCLE ARREST; APOPTOSIS; INTERFERES; PROTECTS; PHASE;
D O I：
10.1016/j.molcatb.2010.09.017
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Andrographolide (1) a major labdane diterpenoidal constituent of a famous traditional Chinese of Andrographis paniculata exhibits a wide spectrum of biological activities including antibacterial, anti-inflammatory and antitumor properties Bioconversion of andrographolide (1) by Aspergillus ochraceus (ATCC 1008) was investigated Five bioconversion products were isolated and identified Their structures were identified to be 8 beta-hydroxy-8(17)-dihydroandrographolide (2), 8 beta-hydroxy-8(17)-dihydro-14-deoxy-11 12-didehydroandrographohde (3) 80-hydroxy-8(17)-dihydro-14-deoxy-11 12-didehydroandrographolide 19-oic acid (4). 14-deoxy-11 12-didehydroandrographolide (5), and 14-deoxy-11 12-didehydroandrographolide 19-oic acid (6) Metabolites 2-4 were novel compounds The proposed biosynthetic pathways of andrographolide by A ochraceus were drawn Most bloconversion products showed potential cytotoxic activities against human breast cancer (MCF-7) human colon cancer (HCT-116) and leukemia (HL-60) cell lines (c) 2010 Elsevier B V All rights reserved
引用
收藏
页码：89 / 93
页数：5
相关论文
共 50 条
  • [41] CYTOTOXIC ACTIVITY OF LUVUNGA SCANDENS AGAINST HUMAN CANCER CELL LINES
    Al-Zikria, Putri Nur Hidayah
    Taher, Muhammad
    Susanti, Deny
    Ichwan, Solachuddin Jauhari Arief
    JURNAL TEKNOLOGI, 2016, 78 (10): : 153 - 157
  • [42] CYTOTOXIC STUDIES OF PACLITAXEL (TAXOL) IN HUMAN TUMOR-CELL LINES
    LIEBMANN, JE
    COOK, JA
    LIPSCHULTZ, C
    TEAGUE, D
    FISHER, J
    MITCHELL, JB
    BRITISH JOURNAL OF CANCER, 1993, 68 (06) : 1104 - 1109
  • [43] GLYOXALASE ACTIVITIES IN HUMAN TUMOR-CELL LINES INVITRO
    AYOUB, F
    ZAMAN, M
    THORNALLEY, P
    MASTERS, J
    ANTICANCER RESEARCH, 1993, 13 (01) : 151 - 156
  • [44] Enantioselective syntheses of (R)- and (S)-argentilactone and their cytotoxic activities against cancer cell lines
    de Fatima, A
    Kohn, LK
    Antônio, MA
    de Carvalho, JE
    Pilli, RA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (20) : 5437 - 5442
  • [45] Synthesis, characterization of vanadium oxide nanostructures and their cytotoxic activities in human cell lines
    Ahmad, Javed
    Wahab, Rizwan
    Siddiqui, Maqsood A.
    Saquib, Quaiser
    Al-Khedhairy, Abdulaziz A.
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2023, 35 (08)
  • [46] Synthesis of piperine-amino acid ester conjugates and study of their cytotoxic activities against human cancer cell lines
    Rama Subba Rao, V.
    Suresh, G.
    Ranga Rao, R.
    Suresh Babu, K.
    Chashoo, G.
    Saxena, A. K.
    Madhusudana Rao, J.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (01) : 38 - 46
  • [47] Cytotoxic activity of novel organotin compounds against different cancer cell lines
    Cherek, Paulina
    Balogova, Michaela
    Damodaran, Krishna
    Ogmundsdottir, Helga M.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Anti-tumor effects of a novel MEK inhibitor in combination with cytotoxic chemotherapy in human melanoma cell lines
    Denton, Cathrine L.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2006, 66 (08)
  • [49] Cytostatic and cytotoxic properties of monensic acid and its biometal(II) complexes against human tumor/non-tumor cell lines
    Alexandrova, Radostina I.
    Zhivkova, Tanya
    Alexandrov, Marin
    Miloshev, Georgi
    Georgieva, Milena
    Pantcheva, Ivayla N.
    Mitewa, Mariana Io
    CENTRAL EUROPEAN JOURNAL OF CHEMISTRY, 2012, 10 (05): : 1464 - 1474
  • [50] Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines
    Manetta, A
    Gamboa, G
    Nasseri, A
    Podnos, YD
    Emma, D
    Dorion, G
    Rawlings, L
    Carpenter, PM
    Bustamante, A
    Patel, J
    Rideout, D
    GYNECOLOGIC ONCOLOGY, 1996, 60 (02) : 203 - 212
12345